
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading UK university is seeking a motivated MSc by Research student for a First Stage Researcher position focused on developing innovative 3D-printed oral drug delivery systems. Candidates should have a keen interest in pharmaceutical sciences, biomedical engineering, or gastrointestinal health. The scholarship covers full tuition costs and offers up to £1,000 for research expenses. Join this exciting project aiming to transform treatment strategies for gastrointestinal conditions.
In 2015, the epilepsy medication Spritamb became the first and still the only FDA‑approved drug manufactured using 3D printing. Since then, research has flourished in developing innovative 3D‑printed formulations.
We are seeking a motivated and curious MSc by Research student to join an exciting interdisciplinary project focused on developing an innovative oral drug delivery system. This project aims to create magnetically guided, 3D‑printed oral formulations designed for precise localisation and controlled drug release within the gastrointestinal tract.
As part of this research, the student will explore pharmaceutical 3D printing techniques, conduct rheological assessments to ensure material printability, and perform rigorous quality control and drug release studies. The formulations developed have the potential to transform treatment strategies for conditions such as inflammatory bowel disease, gastrointestinal cancers, and severe acid reflux.
PhD: Applicants for PhD must hold an undergraduate degree at 2.1 level in Computer Science, Mathematics or a closely related discipline, or an appropriate master’s degree with a minimum overall grade at ‘Merit’ (or non‑UK equivalent as defined by Swansea University). Note for international and European applicants: details of how your qualification compares to the published academic entry requirements can be found on our Country Specific Entry Requirements page.
This scholarship covers the full cost of tuition fees, as well as additional funding of up to £1,000 for associated research expenses.